Rumack B H
Am J Med. 1983 Nov 14;75(5A):104-12. doi: 10.1016/0002-9343(83)90240-1.
Acetaminophen is a remarkably safe agent when used in therapeutic doses. Most reported overdoses of acetaminophen are the result of suicide attempts. The clinical course of patients with toxic blood levels follows four distinct stages. Symptoms of nausea, vomiting, diaphoresis, and anorexia usually begin within seven to 14 hours after ingestion. After 24 to 48 hours, these symptoms may diminish, but SGOT, SGPT, bilirubin, and prothrombin time begin to rise. Peak hepatotoxicity occurs at 72 to 96 hours, and SGOT levels of 20,000 I.U. are not unusual. Oral N-acetylcysteine is the drug of choice for acetaminophen overdose. Intravenous use of N-acetylcysteine is advocated in England, Europe, and elsewhere, but it is not available in the United States. Clinical studies of oral and intravenous N-acetylcysteine clearly demonstrate that the drug has a profound effect on reducing morbidity and mortality if it is administered during the first 16 hours after the overdose. In addition, data from these studies have shown that alcohol taken simultaneously with an overdose of acetaminophen is actually hepatoprotective. Therefore, patients who have consumed alcohol at the time of overdose, or those who are chronic alcoholics, should be managed in the same way as patients with no exposure to alcohol. However, study results also reveal that overdose in children under 10 to 12 years of age follows a distinctly different pattern. These children demonstrate a lesser degree of hepatotoxicity and have only minor increases in transaminase levels.
对乙酰氨基酚在治疗剂量下使用时是一种非常安全的药物。大多数报告的对乙酰氨基酚过量服用案例是自杀未遂导致的。血液中毒性水平患者的临床病程分为四个不同阶段。恶心、呕吐、出汗和厌食症状通常在摄入后7至14小时内开始出现。24至48小时后,这些症状可能会减轻,但谷草转氨酶(SGOT)、谷丙转氨酶(SGPT)、胆红素和凝血酶原时间开始升高。肝毒性在72至96小时达到峰值,SGOT水平达到20000国际单位并不罕见。口服N - 乙酰半胱氨酸是治疗对乙酰氨基酚过量的首选药物。在英国、欧洲和其他地方提倡静脉使用N - 乙酰半胱氨酸,但在美国无法获得。口服和静脉注射N - 乙酰半胱氨酸的临床研究清楚地表明,如果在过量服用后的前16小时内给药,该药物对降低发病率和死亡率有显著效果。此外,这些研究的数据表明,与对乙酰氨基酚过量同时摄入的酒精实际上具有肝脏保护作用。因此,过量服用时饮酒的患者或慢性酒精中毒患者,应与未接触酒精的患者以相同方式处理。然而,研究结果还显示,10至12岁以下儿童的过量服用情况遵循明显不同的模式。这些儿童表现出较低程度的肝毒性,转氨酶水平仅略有升高。